Global Blood Plasma Derivatives Information by type (Albumin, Anti-Thrombin III, Intravenous immunoglobulin (IVIG), Fresh Frozen Plasma (FFP) and others), by application (Hemophilia A, Hemophilia B, HIV, Hepatitis B, Hepatitis C, Thrombocytosis, and others), by end users (Hospitals, clinics, diagnostic centers, blood transfusion centers and others- Forecast to 2023
Blood plasma derivatives are concentrates of specific plasma proteins derived from a pool of plasma donors through a process known as fractionation. They are used in the treatment of various life-threatening diseases. Market Research Future (MRFR) perceives the growth of the global blood plasma derivatives to be healthy at a CAGR of 7.52% over the forecast period of 2017-2023. The blood plasma derivatives market is anticipated to catapult to approximately USD 58 Bn by the end of 2023 from USD 30.5 Bn in 2016.
The rise in global geriatric population also fuels the growth of the blood plasma derivatives market. The elderly population is generally at more risk of acquiring life-threatening diseases which consequently necessitates treatment and further intensifies the growth of the market.
Other driving factors include raising awareness regarding blood and plasma donation and advancement in the preservation techniques of blood plasma. Also, an outlay of substantial amounts on research & development activities and expanding range of clinical applications of blood plasma derivatives are expected to be a tailwind for the growth of the global blood plasma derivatives market.
On a different note, the high costs associated with plasma derivative-based therapies along with the risk of adverse side effects of plasma replacement therapy is a restraining factor to the growth of the global blood plasma derivatives market.
Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/1325
- Fusion Healthcare (India)
- Octapharma AG (Switzerland)
- Baxter International Inc
- Bain Capital
- SK Plasma Co.
- Biotest AG
- CSL Limited
- The global blood plasma derivatives market has been segmented based on type, application, and end user.
- By type, the market has been segmented into anti-thrombin, fresh frozen plasma (FFP), intravenous immunoglobulin (IVIG), Albumin, and others. Other types include Factor VII, Factor IX, and Alpha 1 proteinase inhibitor concentrate.
- By application, the market has been segmented into Hemophilia A, Hemophilia B, HIV, Hepatitis B, Hepatitis C, Thrombocytosis, and others. Other application includes Von Willebrand disease.
- By end user, the market has been segmented into blood transfusion centers, hospitals, diagnostic centers, clinics, and others.
Ask Questions to the Experts @ https://www.marketresearchfuture.com/enquiry/1325
North America, Europe, Asia-Pacific, and the Middle East and Africa are the key markets for blood plasma derivatives. North America is dominating the market for blood plasma derivatives and is expected to expand at a CAGR of 4.25% over the forecast period. The North America blood plasma derivatives market was valued at USD 20 Bn in 2016 and is envisioned to reach USD 35.50 Bn by the end of the forecast period. High awareness regarding the use of blood plasma derivatives coupled affordability of blood plasma derivative-based therapies boosts the growth of the North America market. In addition, the high prevalence of infectious diseases requiring blood plasma derivatives for treatment propels the growth of the market.
Europe follows North America closely and is the second largest market for blood plasma derivatives driven by extensive R&D activities and rise in a number of research institutions. The Europe blood plasma derivatives market is expected to grow at a CAGR 3.8% over the forecast period.
Asia Pacific is slated to emerge as the fastest growing market for blood plasma derivatives. Growing prevalence of life-threatening diseases couple with high awareness supports the growth of the market.
Access Full Report Details and TOC Exclusively @ https://www.marketresearchfuture.com/reports/blood-plasma-derivatives-market-1325
About Market Research Future:
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar, Pune
+1 646 845 9312